v3.25.2
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (25,614) $ (46,222) $ (55,466) $ (93,729)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 152,082,284 147,414,095 150,646,632 146,600,811
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.17) $ (0.31) $ (0.37) $ (0.64)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 152,082,284 147,414,095 150,646,632 146,600,811
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.17) $ (0.31) $ (0.37) $ (0.64)